Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 26 October 2022
Adhoc Press Release
Kuros reports 73% increase in MagnetOs sales in first nine months of 2022
Press Release, 3 October 2022
Adhoc Press Release
Kuros Biosciences Appoints Chris Fair as Chief Operating Officer
Press Release, 15 September 2022
Adhoc Press Release
Kuros Biosciences announces successful CHF 6.0 million private placement
Press Release, 9 August 2022
Adhoc Press Release
Kuros Biosciences reports results for the first six months of 2022
Press Release, 8 June 2022
Adhoc Press Release
Annual General Meeting of Kuros Biosciences approves all resolutions
Press Release, 2 June 2022
Adhoc Press Release
Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
adhoc-press-releases
2022